Biotech · Private company
Io Therapeutics
Track this companyFree. Adds Io Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- IRX4204Phase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- NRX 194204Phase 2 · Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- erlotinibPhase 1 · Lung Cancer, Nonsmall CellClinicalTrials.gov · fetched Nov 12, 2026
- IRX4204Phase 1 · Lung Cancer, Nonsmall CellClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque PsoriasisPHASE2 · SUSPENDED · started Mar 1, 2026ClinicalTrials.gov NCT06723171 · fetched Nov 12, 2026
- Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLCPHASE1 · TERMINATED · started Dec 7, 2016ClinicalTrials.gov NCT02991651 · fetched Nov 12, 2026
- Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate CancerPHASE2 · COMPLETED · started Aug 1, 2011ClinicalTrials.gov NCT01540071 · fetched Nov 12, 2026